QS Investors’s West Pharmaceutical WST Stock Holding History

QS Investors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$11.4M	Sell	31,661 -5,204	-14%	-$1.72M	0.13%	111
2021 Q1	$10.4M	Buy	36,865 +1,071	+3%	+$307K	0.12%	132
2020 Q4	$10.1M	Buy	35,794 +226	+0.6%	+$63.4K	0.12%	135
2020 Q3	$9.78M	Buy	35,568 +2,784	+8%	+$737K	0.13%	131
2020 Q2	$7.45M	Buy	32,784 +11,184	+52%	+$2.2M	0.1%	162
2020 Q1	$3.29M	Buy	21,600 +19,600	+980%	+$3.02M	0.05%	277
2019 Q4	$304K	Sell	2,000 -700	-26%	-$102K	﹤0.01%	1073
2019 Q3	$383K	Hold	2,700	–	–	﹤0.01%	1025
2019 Q2	$338K	Hold	2,700	–	–	﹤0.01%	1083
2019 Q1	$298K	Sell	2,700 -6	-0.2%	-$624	﹤0.01%	1122
2018 Q4	$266K	Hold	2,706	–	–	﹤0.01%	1054
2018 Q3	$334K	Hold	2,706	–	–	﹤0.01%	1055
2018 Q2	$269K	Hold	2,706	–	–	﹤0.01%	1117
2018 Q1	$239K	Hold	2,706	–	–	﹤0.01%	1117
2017 Q4	$267K	Hold	2,706	–	–	﹤0.01%	1103
2017 Q3	$260K	Hold	2,706	–	–	﹤0.01%	1130
2017 Q2	$256K	Hold	2,706	–	–	﹤0.01%	1119
2017 Q1	$221K	Buy	2,706 +2,700	+45,000%	+$226K	﹤0.01%	1197
2016 Q4	$1K	Hold	6	–	–	﹤0.01%	1789
2016 Q3	$1K	Hold	6	–	–	﹤0.01%	1779
2016 Q2	$1K	Hold	6	–	–	﹤0.01%	1833
2016 Q1	$1K	Hold	6	–	–	﹤0.01%	1809
2015 Q4	$1K	Buy	+6	New	+$361	﹤0.01%	1859

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

QS Investors's WST Position: Q2 2021 in Review

QS Investors reduced its West Pharmaceutical (WST) stake by 14% in Q2 2021, selling an estimated $1.72M and leaving 31,661 shares worth $11.4M. The position accounts for 0.13% of the portfolio, ranked #111.

QS Investors first reported a position in WST in Q4 2015 and has held it in 23 quarters since. 640 funds tracked by Wall St. Rank hold WST as of Q2 2021.

QS Investors held 31,661 shares of West Pharmaceutical worth $11.4M as of Q2 2021.
QS Investors sold 5,204 West Pharmaceutical shares in Q2 2021, an estimated $1.72M.
West Pharmaceutical made up 0.13% of QS Investors's portfolio in Q2 2021, its #111 holding.
QS Investors first reported a position in West Pharmaceutical in Q4 2015 and has held it in 23 quarters since.
640 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.